Unraveling biochemical pathways affected by mitochondrial dysfunctions using metabolomic approaches

Metabolites

Volumn 4, Issue 3, 2014, Pages 831-878

  Demine, Stéphane ^a   Reddy, Nagabushana ^a   Renard, Patricia ^a   Raes, Martine ^a   Arnould, Thierry ^a  

^a University of Namur   (Belgium)

Author keywords

Mass spectrometry; Metabolic syndrome; Metabolites; Metabolomics; Mitochondria; Mitochondrial uncoupling; NMR; Obesity; Type II diabetes mellitus; Uncoupling proteins

Indexed keywords

EID: 85016478818     PISSN: None     EISSN: 22181989     Source Type: Journal    
DOI: 10.3390/metabo4030831     Document Type: Review

References (275)

1. Beger, R.D. A review of applications of metabolomics in cancer. Metabolites 2013, 3, 552-574.
2. Fiehn, O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genom. 2001, 2, 155-168.
3. Nicholson, J.K.; Lindon, J.C.; Holmes, E. "Metabonomics": Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological nmr spectroscopic data. Xenobiotica 1999, 29, 1181-1189.
4. Robertson, D.G. Metabonomics in toxicology: A review. Toxicol. Sci. 2005, 85, 809-822.
5. Liesenfeld, D.B.; Habermann, N.; Owen, R.W.; Scalbert, A.; Ulrich, C.M. Review of mass spectrometry-based metabolomics in cancer research. Canc. Epidemiol. Biomarkers Prev. 2013, 22, 2182-2201.
6. Vermeersch, K.A.; Styczynski, M.P. Applications of metabolomics in cancer research. J. Carcinog. 2013, doi: 10.4103/1477-3163
7. Gray, M.W.; Burger, G.; Lang, B.F. The origin and early evolution of mitochondria. Genome Biol. 2001, 2, Reviews 1018.
8. Acin-Perez, R.; Fernandez-Silva, P.; Peleato, M.L.; Perez-Martos, A.; Enriquez, J.A. Respiratory active mitochondrial supercomplexes. Mol. Cell 2008, 32, 529-539.
9. Schagger, H.; Pfeiffer, K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J. 2000, 19, 1777-1783.
10. Schagger, H.; Pfeiffer, K. The ratio of oxidative phosphorylation complexes i-v in bovine heart mitochondria and the composition of respiratory chain supercomplexes. J. Biol. Chem. 2001, 276, 37861-37867.
11. Strogolova, V.; Furness, A.; Robb-McGrath, M.; Garlich, J.; Stuart, R.A. Rcf1 and rcf2, members of the hypoxia-induced gene 1 protein family, are critical components of the mitochondrial cytochrome bc1-cytochrome c oxidase supercomplex. Mol. Cell. Biol. 2012, 32, 1363-1373.
12. Ikeda, K.; Shiba, S.; Horie-Inoue, K.; Shimokata, K.; Inoue, S. A stabilizing factor for mitochondrial respiratory supercomplex assembly regulates energy metabolism in muscle. Nat. Commun. 2013, 4, Article 2147.
13. Wenz, T.; Hielscher, R.; Hellwig, P.; Schagger, H.; Richers, S.; Hunte, C. Role of phospholipids in respiratory cytochrome bc (1) complex catalysis and supercomplex formation. Biochimica Biophys. Acta 2009, 1787, 609-616.
14. Bottinger, L.; Horvath, S.E.; Kleinschroth, T.; Hunte, C.; Daum, G.; Pfanner, N.; Becker, T. Phosphatidylethanolamine and cardiolipin differentially affect the stability of mitochondrial respiratory chain supercomplexes. J. Mol. Biol. 2012, 423, 677-686.
15. Bazan, S.; Mileykovskaya, E.; Mallampalli, V.K.; Heacock, P.; Sparagna, G.C.; Dowhan, W. Cardiolipin-dependent reconstitution of respiratory supercomplexes from purified saccharomyces cerevisiae complexes iii and iv. J. Biol. Chem. 2013, 288, 401-411.
16. McBride, H.M.; Neuspiel, M.; Wasiak, S. Mitochondria: More than just a powerhouse. Curr. Biol. 2006, 16, 551-560.
17. Tait, S.W.; Green, D.R. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 2010, 11, 621-632.
18. Kubli, D.A.; Gustafsson, A.B. Mitochondria and mitophagy: The yin and yang of cell death control. Circ. Res. 2012, 111, 1208-1221.
19. Rizzuto, R.; de Stefani, D.; Raffaello, A.; Mammucari, C. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev.Mol. Cell Biol. 2012, 13, 566-578.
20. Williams, G.S.; Boyman, L.; Chikando, A.C.; Khairallah, R.J.; Lederer, W.J. Mitochondrial calcium uptake. Proc. Natl. Acad. Sci. USA 2013, 110, 10479-10486.
21. Tait, S.W.; Green, D.R. Mitochondria and cell signalling. J. Cell Sci. 2012, 125, 807-815.
22. Levine, A.J.; Puzio-Kuter, A.M. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010, 330, 1340-1344.
23. Cardaci, S.; Ciriolo, M.R. Tca cycle defects and cancer: When metabolism tunes redox state. Int. J. Cell Biol. 2012, 2012, Article 161837.
24. Lazarow, P.B. Rat liver peroxisomes catalyze the beta oxidation of fatty acids. J. Biol. Chem. 1978, 253, 1522-1528.
25. Foster, D.W. The role of the carnitine system in human metabolism. Ann. NY Acad. Sci. 2004, 1033, 1-16.
26. Bartlett, K.; Eaton, S. Mitochondrial beta-oxidation. Eur. J. Biochem. 2004, 271, 462-469.
27. Cho, S.Y.; Kim, J.H.; Paik, Y.K. Cholesterol biosynthesis from lanosterol: Differential inhibition of sterol delta 8-isomerase and other lanosterol-converting enzymes by tamoxifen. Mol. Cells 1998, 8, 233-239.
28. Cotter, D.G.; Schugar, R.C.; Crawford, P.A. Ketone body metabolism and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 2013, 304, 1060-1076.
29. Meng, M.; Chen, S.; Lao, T.; Liang, D.; Sang, N. Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle 2010, 9, 3921-3932.
30. Nicklin, P.; Bergman, P.; Zhang, B.; Triantafellow, E.; Wang, H.; Nyfeler, B.; Yang, H.; Hild, M.; Kung, C.; Wilson, C.; et al. Bidirectional transport of amino acids regulates mtor and autophagy. Cell 2009, 136, 521-534.
31. Smith, D.D., Jr.; Campbell, J.W. Distribution of glutamine synthetase and carbamoyl-phosphate synthetase i in vertebrate liver. Proc. Natl. Acad. Sci. USA 1988, 85, 160-164.
32. Boza, J.J.; Moennoz, D.; Bournot, C.E.; Blum, S.; Zbinden, I.; Finot, P.A.; Ballevre, O. Role of glutamine on the de novo purine nucleotide synthesis in caco-2 cells. Eur. J. Nutr. 2000, 39, 38-46.
33. Cory, J.G.; Cory, A.H. Critical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: Asparaginase treatment in childhood acute lymphoblastic leukemia. In Vivo 2006, 20, 587-589.
34. Mouilleron, S.; Badet-Denisot, M.A.; Golinelli-Pimpaneau, B. Glutamine binding opens the ammonia channel and activates glucosamine-6p synthase. J. Biol. Chem. 2006, 281, 4404-4412.
35. Dang, C.V. Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? Cell Cycle 2010, 9, 3884-3886.
36. Metallo, C.M.; Gameiro, P.A.; Bell, E.L.; Mattaini, K.R.; Yang, J.; Hiller, K.; Jewell, C.M.; Johnson, Z.R.; Irvine, D.J.; Guarente, L.; et al. Reductive glutamine metabolism by idh1 mediates lipogenesis under hypoxia. Nature 2012, 481, 380-384.
37. Brosnan, J.T.; Brosnan, M.E. Branched-chain amino acids: Enzyme and substrate regulation. J. Nutr. 2006, 136, 207S-211S.
38. Elia, M.; Livesey, G. Effects of ingested steak and infused leucine on forelimb metabolism in man and the fate of the carbon skeletons and amino groups of branched-chain amino acids. Clin. Sci. 1983, 64, 517-526.
39. Suryawan, A.; Hawes, J.W.; Harris, R.A.; Shimomura, Y.; Jenkins, A.E.; Hutson, S.M. A molecular model of human branched-chain amino acid metabolism. Am. J. Clin. Nutr. 1998, 68, 72-81.
40. Tajiri, K.; Shimizu, Y. Branched-chain amino acids in liver diseases. World J. Gastroenterol. 2013, 19, 7620-7629.
41. D'Antona, G.; Ragni, M.; Cardile, A.; Tedesco, L.; Dossena, M.; Bruttini, F.; Caliaro, F.; Corsetti, G.; Bottinelli, R.; Carruba, M.O.; et al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metabol. 2010, 12, 362-372.
42. Strum, J.C.; Shehee, R.; Virley, D.; Richardson, J.; Mattie, M.; Selley, P.; Ghosh, S.; Nock, C.; Saunders, A.; Roses, A. Rosiglitazone induces mitochondrial biogenesis in mouse brain. J. Alzheim. Dis. 2007, 11, 45-51.
43. Tontonoz, P.; Hu, E.; Spiegelman, B.M. Stimulation of adipogenesis in fibroblasts by ppar gamma 2, a lipid-activated transcription factor. Cell 1994, 79, 1147-1156.
44. Ichikawa, K.; Okabayashi, T.; Shima, Y.; Iiyama, T.; Takezaki, Y.; Munekage, M.; Namikawa, T.; Sugimoto, T.; Kobayashi, M.; Mimura, T.; et al. Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride. Mol. Biol. Rep. 2012, 39, 10803-10810.
45. Blomstrand, E.; Eliasson, J.; Karlsson, H.K.; Kohnke, R. Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J. Nutr. 2006, 136, 269S-273S.
46. Nishitani, S.; Matsumura, T.; Fujitani, S.; Sonaka, I.; Miura, Y.; Yagasaki, K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem. Biophys. Res. Comm. 2002, 299, 693-696.
47. Nishitani, S.; Takehana, K.; Fujitani, S.; Sonaka, I. Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288, G1292-G1300.
48. Hinault, C.; Mothe-Satney, I.; Gautier, N.; Lawrence, J.C., Jr.; van Obberghen, E. Amino acids and leucine allow insulin activation of the pkb/mtor pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice. FASEB J. 2004, 18, 1894-1896.
49. Miller, W.L.; Bose, H.S. Early steps in steroidogenesis: Intracellular cholesterol trafficking. J. Lipid Res. 2011, 52, 2111-2135.
50. Zhao, S.; Xu, W.; Jiang, W.; Yu, W.; Lin, Y.; Zhang, T.; Yao, J.; Zhou, L.; Zeng, Y.; Li, H.; et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327, 1000-1004.
51. Jiang, W.; Wang, S.; Xiao, M.; Lin, Y.; Zhou, L.; Lei, Q.; Xiong, Y.; Guan, K.L.; Zhao, S. Acetylation regulates gluconeogenesis by promoting pepck1 degradation via recruiting the ubr5 ubiquitin ligase. Mol. Cell 2011, 43, 33-44.
52. Xiong, Y.; Guan, K.L. Mechanistic insights into the regulation of metabolic enzymes by acetylation. J. Cell Biol. 2012, 198, 155-164.
53. Brand, M.D.; Nicholls, D.G. Assessing mitochondrial dysfunction in cells. Biochem. J. 2011, 435, 297-312.
54. Tuppen, H.A.; Blakely, E.L.; Turnbull, D.M.; Taylor, R.W. Mitochondrial DNA mutations and human disease. Biochim. Biophys. Acta 2010, 1797, 113-128.
55. Park, C.B.; Larsson, N.G. Mitochondrial DNA mutations in disease and aging. J. Cell Biol. 2011, 193, 809-818.
56. Dudkina, N.V.; Kouril, R.; Peters, K.; Braun, H.P.; Boekema, E.J. Structure and function of mitochondrial supercomplexes. Biochim. Biophys. Acta 2010, 1797, 664-670.
57. Vannuvel, K.; Renard, P.; Raes, M.; Arnould, T. Functional and morphological impact of er stress on mitochondria. J. Cell. Physiol. 2013, 228, 1802-1818.
58. Pellegrino, M.W.; Nargund, A.M.; Haynes, C.M. Signaling the mitochondrial unfolded protein response. Biochim. Biophys. Acta 2013, 1833, 410-416.
59. Rousset, S.; Alves-Guerra, M.C.; Mozo, J.; Miroux, B.; Cassard-Doulcier, A.M.; Bouillaud, F.; Ricquier, D. The biology of mitochondrial uncoupling proteins. Diabetes 2004, 53, S130-S135.
60. Ricquier, D.; Bouillaud, F.; Toumelin, P.; Mory, G.; Bazin, R.; Arch, J.; Penicaud, L. Expression of uncoupling protein mrna in thermogenic or weakly thermogenic brown adipose tissue. Evidence for a rapid beta-adrenoreceptor-mediated and transcriptionally regulated step during activation of thermogenesis. J. Biol. Chem. 1986, 261, 13905-13910.
61. Levy, S.E.; Chen, Y.S.; Graham, B.H.; Wallace, D.C. Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. Gene 2000, 254, 57-66.
62. Stepien, G.; Torroni, A.; Chung, A.B.; Hodge, J.A.; Wallace, D.C. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J. Biol.Chem. 1992, 267, 14592-14597.
63. Brower, J.V.; Rodic, N.; Seki, T.; Jorgensen, M.; Fliess, N.; Yachnis, A.T.; McCarrey, J.R.; Oh, S.P.; Terada, N. Evolutionarily conserved mammalian adenine nucleotide translocase 4 is essential for spermatogenesis. J. Biol. Chem. 2007, 282, 29658-29666.
64. Brand, M.D.; Pakay, J.L.; Ocloo, A.; Kokoszka, J.; Wallace, D.C.; Brookes, P.S.; Cornwall, E.J. The basal proton conductance of mitochondria depends on adenine nucleotide translocase content. Biochem. J. 2005, 392, 353-362.
65. Liu, Y.; Chen, X.J. Adenine nucleotide translocase, mitochondrial stress, and degenerative cell death. Oxidative Med. Cell. Longev. 2013, 2013, Article 146860.
66. Liu, J.; Li, J.; Li, W.J.; Wang, C.M. The role of uncoupling proteins in diabetes mellitus. J. Diabetes Res. 2013, 2013, Article 585897.
67. Klingenberg, M.; Winkler, E. The reconstituted isolated uncoupling protein is a membrane potential driven h+ translocator. EMBO J. 1985, 4, 3087-3092.
68. Matthias, A.; Ohlson, K.B.; Fredriksson, J.M.; Jacobsson, A.; Nedergaard, J.; Cannon, B. Thermogenic responses in brown fat cells are fully ucp1-dependent. Ucp2 or ucp3 do not substitute for ucp1 in adrenergically or fatty scid-induced thermogenesis. J. Biol. Chem. 2000, 275, 25073-25081.
69. Cadrin, M.; Tolszczuk, M.; Guy, J.; Pelletier, G.; Freeman, K.B.; Bukowiecki, L.J. Immunohistochemical identification of the uncoupling protein in rat brown adipose tissue. J. Histochem. Cytochem. 1985, 33, 150-154.
70. Petrovic, N.; Walden, T.B.; Shabalina, I.G.; Timmons, J.A.; Cannon, B.; Nedergaard, J. Chronic peroxisome proliferator-activated receptor gamma (ppargamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, ucp1-containing adipocytes molecularly distinct from classic brown adipocytes. J. Biol. Chem. 2010, 285, 7153-7164.
71. Boss, O.; Samec, S.; Paoloni-Giacobino, A.; Rossier, C.; Dulloo, A.; Seydoux, J.; Muzzin, P.; Giacobino, J.P. Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 1997, 408, 39-42.
72. Sale, M.M.; Hsu, F.C.; Palmer, N.D.; Gordon, C.J.; Keene, K.L.; Borgerink, H.M.; Sharma, A.J.; Bergman, R.N.; Taylor, K.D.; Saad, M.F.; et al. The uncoupling protein 1 gene, ucp1, is expressed in mammalian islet cells and associated with acute insulin response to glucose in african american families from the iras family study. BMC Endocr. Disord. 2007, 7, 1.
73. Chen, Y.; Li, Z.Y.; Yang, Y.; Zhang, H.J. Uncoupling protein 2 regulates glucagon-like peptide-1 secretion in l-cells. World J. Gastroenterol. 2012, 18, 3451-3457.
74. Fleury, C.; Neverova, M.; Collins, S.; Raimbault, S.; Champigny, O.; Levi-Meyrueis, C.; Bouillaud, F.; Seldin, M.F.; Surwit, R.S.; Ricquier, D.; et al. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 1997, 15, 269-272.
75. Boss, O.; Samec, S.; Dulloo, A.; Seydoux, J.; Muzzin, P.; Giacobino, J.P. Tissue-dependent upregulation of rat uncoupling protein-2 expression in response to fasting or cold. FEBS Lett. 1997, 412, 111-114.
76. Li, W.; Nichols, K.; Nathan, C.A.; Zhao, Y. Mitochondrial uncoupling protein 2 is up-regulated in human head and neck, skin, pancreatic, and prostate tumors. Canc. Biomarkers 2013, 13, 377-383.
77. Li, Y.; Maedler, K.; Shu, L.; Haataja, L. Ucp-2 and ucp-3 proteins are differentially regulated in pancreatic beta-cells. PloS One 2008, doi:10.1371/journal.pone.0001397.
78. Mao, W.; Yu, X.X.; Zhong, A.; Li, W.; Brush, J.; Sherwood, S.W.; Adams, S.H.; Pan, G. Ucp4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. FEBS Lett. 1999, 443, 326-330.
79. Yu, X.X.; Mao, W.; Zhong, A.; Schow, P.; Brush, J.; Sherwood, S.W.; Adams, S.H.; Pan, G. Characterization of novel ucp5/bmcp1 isoforms and differential regulation of ucp4 and ucp5 expression through dietary or temperature manipulation. FASEB J. 2000, 14, 1611-1618.
80. Bouillaud, F.; Ricquier, D.; Thibault, J.; Weissenbach, J. Molecular approach to thermogenesis in brown adipose tissue: Cdna cloning of the mitochondrial uncoupling protein. Proc. Natl. Acad. of Sci. USA 1985, 82, 445-448.
81. Kukat, A.; Dogan, S.A.; Edgar, D.; Mourier, A.; Jacoby, C.; Maiti, P.; Mauer, J.; Becker, C.; Senft, K.; Wibom, R.; et al. Loss of ucp2 attenuates mitochondrial dysfunction without altering ros production and uncoupling activity. PLoS Genet. 2014, 10, e1004385.
82. Adjeitey, C.N.; Mailloux, R.J.; Dekemp, R.A.; Harper, M.E. Mitochondrial uncoupling in skeletal muscle by ucp1 augments energy expenditure and glutathione content while mitigating ros production. Am. J. Physiol. Endocrinol. Metabol. 2013, 305, E405-E415.
83. Shabalina, I.G.; Vrbacky, M.; Pecinova, A.; Kalinovich, A.V.; Drahota, Z.; Houstek, J.; Mracek, T.; Cannon, B.; Nedergaard, J. Ros production in brown adipose tissue mitochondria: The question of ucp1-dependence. Biochim. Biophys. Acta 2014, doi:10.1016/j.bbabio.2014.04.005.
84. Shabalina, I.G.; Petrovic, N.; de Jong, J.M.; Kalinovich, A.V.; Cannon, B.; Nedergaard, J. Ucp1 in brite/beige adipose tissue mitochondria is functionally thermogenic. Cell Rep. 2013, 5, 1196-1203.
85. Wang, Y.; Huang, L.; Abdelrahim, M.; Cai, Q.; Truong, A.; Bick, R.; Poindexter, B.; Sheikh-Hamad, D. Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial ucp2. J. Leukocyte Biol. 2009, 86, 981-988.
86. Tian, X.Y.; Wong, W.T.; Xu, A.; Lu, Y.; Zhang, Y.; Wang, L.; Cheang, W.S.; Wang, Y.; Yao, X.; Huang, Y. Uncoupling protein-2 protects endothelial function in diet-induced obese mice. Circ. Res. 2012, 110, 1211-1216.
87. Dando, I.; Fiorini, C.; Pozza, E.D.; Padroni, C.; Costanzo, C.; Palmieri, M.; Donadelli, M. Ucp2 inhibition triggers ros-dependent nuclear translocation of gapdh and autophagic cell death in pancreatic adenocarcinoma cells. Biochim. Biophys. Acta 2013, 1833, 672-679.
88. Vozza, A.; Parisi, G.; De Leonardis, F.; Lasorsa, F.M.; Castegna, A.; Amorese, D.; Marmo, R.; Calcagnile, V.M.; Palmieri, L.; Ricquier, D.; et al. Ucp2 transports c4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc. Natl. Acad. Sci. USA 2014, 111, 960-965.
89. Clapham, J.C.; Arch, J.R.; Chapman, H.; Haynes, A.; Lister, C.; Moore, G.B.; Piercy, V.; Carter, S.A.; Lehner, I.; Smith, S.A.; et al. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000, 406, 415-418.
90. Himms-Hagen, J.; Harper, M.E. Physiological role of ucp3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: An hypothesis. Exp. Biol. Med. 2001, 226, 78-84.
91. 2+ uniport. Nat. Cell Biol. 2007, 9, 445-452.
92. Hoang, T.; Smith, M.D.; Jelokhani-Niaraki, M. Toward understanding the mechanism of ion transport activity of neuronal uncoupling proteins ucp2, ucp4, and ucp5. Biochemistry 2012, 51, 4004-4014.
93. Gao, C.L.; Zhu, J.G.; Zhao, Y.P.; Chen, X.H.; Ji, C.B.; Zhang, C.M.; Zhu, C.; Xia, Z.K.; Peng, Y.Z.; Guo, X.R. Mitochondrial dysfunction is induced by the overexpression of ucp4 in 3t3-l1 adipocytes. Int. J. Mol. Med. 2010, 25, 71-80.
94. Ho, J.W.; Ho, P.W.; Zhang, W.Y.; Liu, H.F.; Kwok, K.H.; Yiu, D.C.; Chan, K.H.; Kung, M.H.; Ramsden, D.B.; Ho, S.L. Transcriptional regulation of ucp4 by nf-kappab and its role in mediating protection against mpp+ toxicity. Free Radic. Biol. Med. 2010, 49, 192-204.
95. Pfeiffer, M.; Kayzer, E.B.; Yang, X.; Abramson, E.; Kenaston, M.A.; Lago, C.U.; Lo, H.H.; Sedensky, M.M.; Lunceford, A.; Clarke, C.F.; et al. Caenorhabditis elegans ucp4 protein controls complex ii-mediated oxidative phosphorylation through succinate transport. J. Biol. Chem. 2011, 286, 37712-37720.
96. Fukai, T.; Ushio-Fukai, M. Superoxide dismutases: Role in redox signaling, vascular function, and diseases. Antioxid. Redox Sign. 2011, 15, 1583-1606.
97. Kirkman, H.N.; Gaetani, G.F. Mammalian catalase: A venerable enzyme with new mysteries. Trends Biochem. Sci. 2007, 32, 44-50.
98. Lu, J.; Holmgren, A. The thioredoxin antioxidant system. Free Radic. Biol. Med. 2014, 66, 75-87.
99. Wood, Z.A.; Schroder, E.; Robin Harris, J.; Poole, L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 2003, 28, 32-40.
100. Lundberg, M.; Johansson, C.; Chandra, J.; Enoksson, M.; Jacobsson, G.; Ljung, J.; Johansson, M.; Holmgren, A. Cloning and expression of a novel human glutaredoxin (grx2) with mitochondrial and nuclear isoforms. J. Biol. Chem. 2001, 276, 26269-26275.
101. Nogueiras, R.; Habegger, K.M.; Chaudhary, N.; Finan, B.; Banks, A.S.; Dietrich, M.O.; Horvath, T.L.; Sinclair, D.A.; Pfluger, P.T.; Tschop, M.H. Sirtuin 1 and sirtuin 3: Physiological modulators of metabolism. Physiol. Rev. 2012, 92, 1479-1514.
102. Cui, Y.; Xu, X.; Bi, H.; Zhu, Q.; Wu, J.; Xia, X.; Qiushi, R.; Ho, P.C. Expression modification of uncoupling proteins and mnsod in retinal endothelial cells and pericytes induced by high glucose: The role of reactive oxygen species in diabetic retinopathy. Exp. Eye Res. 2006, 83, 807-816.
103. Dymkowska, D.; Drabarek, B.; Podszywalow-Bartnicka, P.; Szczepanowska, J.; Zablocki, K. Hyperglycaemia modifies energy metabolism and reactive oxygen species formation in endothelial cells in vitro. Arch. Biochem. Biophys. 2014, 542, 7-13.
104. Koziel, A.; Woyda-Ploszczyca, A.; Kicinska, A.; Jarmuszkiewicz, W. The influence of high glucose on the aerobic metabolism of endothelial ea.Hy926 cells. Pflugers Arch. Eur. J. Physiol. 2012, 464, 657-669.
105. Matsuzaki, H.; Daitoku, H.; Hatta, M.; Aoyama, H.; Yoshimochi, K.; Fukamizu, A. Acetylation of foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc. Natl. Acad. Sci. USA 2005, 102, 11278-11283.
106. Nakae, J.; Cao, Y.; Oki, M.; Orba, Y.; Sawa, H.; Kiyonari, H.; Iskandar, K.; Suga, K.; Lombes, M.; Hayashi, Y. Forkhead transcription factor foxo1 in adipose tissue regulates energy storage and expenditure. Diabetes 2008, 57, 563-576.
107. Komelina, N.P.; Amerkhanov, Z.G. A comparative study of the inhibitory effects of purine nucleotides and carboxyatractylate on the uncoupling protein-3 and adenine nucleotide translocase. Acta Biochim. Pol. 2010, 57, 413-419.
108. Winkler, E.; Wachter, E.; Klingenberg, M. Identification of the ph sensor for nucleotide binding in the uncoupling protein from brown adipose tissue. Biochemistry 1997, 36, 148-155.
109. Winkler, E.; Klingenberg, M. Photoaffinity labeling of the nucleotide-binding site of the uncoupling protein from hamster brown adipose tissue. Eur. J. Biochem. 1992, 203, 295-304.
110. Arechaga, I.; Ledesma, A.; Rial, E. The mitochondrial uncoupling protein ucp1: A gated pore. IUBMB Life 2001, 52, 165-173.
111. Du, Y.; Meng, Q.; Zhang, Q.; Guo, F. Isoleucine or valine deprivation stimulates fat loss via increasing energy expenditure and regulating lipid metabolism in wat. Amino Acids 2012, 43, 725-734.
112. Cheng, Y.; Meng, Q.; Wang, C.; Li, H.; Huang, Z.; Chen, S.; Xiao, F.; Guo, F. Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (ucp1) in brown adipose tissue. Diabetes 2010, 59, 17-25.
113. Cheng, Y.; Zhang, Q.; Meng, Q.; Xia, T.; Huang, Z.; Wang, C.; Liu, B.; Chen, S.; Xiao, F.; Du, Y.; et al. Leucine deprivation stimulates fat loss via increasing crh expression in the hypothalamus and activating the sympathetic nervous system. Mol. Endocrinol. 2011, 25, 1624-1635.
114. Bernardi, P.; Penzo, D.; Wojtczak, L. Mitochondrial energy dissipation by fatty acids. Mechanisms and implications for cell death. Vitam. Horm. 2002, 65, 97-126.
115. Schonfeld, P.; Wojtczak, L. Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. Biochim. Biophys. Acta 2007, 1767, 1032-1040.
116. Cole, M.A.; Murray, A.J.; Cochlin, L.E.; Heather, L.C.; McAleese, S.; Knight, N.S.; Sutton, E.; Jamil, A.A.; Parassol, N.; Clarke, K. A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res. Cardiol. 2011, 106, 447-457.
117. Lambertucci, R.H.; Leandro, C.G.; Vinolo, M.A.; Nachbar, R.T.; Dos Reis Silveira, L.; Hirabara, S.M.; Curi, R.; Pithon-Curi, T.C. The effects of palmitic acid on nitric oxide production by rat skeletal muscle: Mechanism via superoxide and inos activation. Cell. Physiol. Biochem 2012, 30, 1169-1180.
118. Divakaruni, A.S.; Humphrey, D.M.; Brand, M.D. Fatty acids change the conformation of uncoupling protein 1 (ucp1). J. Biol. Chem. 2012, 287, 36845-36853.
119. Fedorenko, A.; Lishko, P.V.; Kirichok, Y. Mechanism of fatty-acid-dependent ucp1 uncoupling in brown fat mitochondria. Cell 2012, 151, 400-413.
120. Beck, V.; Jaburek, M.; Demina, T.; Rupprecht, A.; Porter, R.K.; Jezek, P.; Pohl, E.E. Polyunsaturated fatty acids activate human uncoupling proteins 1 and 2 in planar lipid bilayers. FASEB J. 2007, 21, 1137-1144.
121. Taltavull, N.; Munoz-Cortes, M.; Lluis, L.; Jove, M.; Fortuno, A.; Molinar-Toribio, E.; Torres, J.L.; Pazos, M.; Medina, I.; Nogues, M.R. Eicosapentaenoic acid/docosahexaenoic acid 1:1 ratio improves histological alterations in obese rats with metabolic syndrome. Lipids Health Dis. 2014, doi:10.1186/1476-511X-13-31.
122. Oster, R.T.; Tishinsky, J.M.; Yuan, Z.; Robinson, L.E. Docosahexaenoic acid increases cellular adiponectin mrna and secreted adiponectin protein, as well as ppargamma mrna, in 3t3-l1 adipocytes. Appl. Physiol. Nutr. Metabol. 2010, 35, 783-789.
123. Sadurskis, A.; Dicker, A.; Cannon, B.; Nedergaard, J. Polyunsaturated fatty acids recruit brown adipose tissue: Increased ucp content and nst capacity. Am. J. Physiol. 1995, 269, E351-E360.
124. Jeckel, K.M.; Veeramachaneni, D.N.; Chicco, A.J.; Chapman, P.L.; Mulligan, C.M.; Hegarty, J.R.; Pagliassotti, M.J.; Ferguson, L.A.; Bouma, G.J.; Frye, M.A. Docosahexaenoic acid supplementation does not improve western diet-induced cardiomyopathy in rats. PloS One 2012, doi: 10.1371/journal.pone.0051994.
125. Wu, Y.; Zhang, C.; Dong, Y.; Wang, S.; Song, P.; Viollet, B.; Zou, M.H. Activation of the amp-activated protein kinase by eicosapentaenoic acid (epa, 20:5 n-3) improves endothelial function in vivo. PloS One 2012, 7, e35508.
126. Flachs, P.; Horakova, O.; Brauner, P.; Rossmeisl, M.; Pecina, P.; Franssen-van Hal, N.; Ruzickova, J.; Sponarova, J.; Drahota, Z.; Vlcek, C.; et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 2005, 48, 2365-2375.
127. Janovska, P.; Flachs, P.; Kazdova, L.; Kopecky, J. Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis. Physiol.Res. 2013, 62, 153-161.
128. Flachs, P.; Ruhl, R.; Hensler, M.; Janovska, P.; Zouhar, P.; Kus, V.; Macek Jilkova, Z.; Papp, E.; Kuda, O.; Svobodova, M.; et al. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 2011, 54, 2626-2638.
129. Flachs, P.; Rossmeisl, M.; Bryhn, M.; Kopecky, J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin. Sci. 2009, 116, 1-16.
130. Griffiths, D.E.; Cain, K.; Hyams, R.L. Studies of energy-linked reactions. Inhibition of oxidative phosphorylation by dl-8-methyldihydrolipoate. Biochem. J. 1977, 164, 699-704.
131. Valdecantos, M.P.; Perez-Matute, P.; Gonzalez-Muniesa, P.; Prieto-Hontoria, P.L.; Moreno-Aliaga, M.J.; Martinez, J.A. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function. J. Nutr. Biochem. 2012, 23, 1676-1684.
132. Wang, Y.; Li, X.; Guo, Y.; Chan, L.; Guan, X. Alpha-lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabol. Clin. Exp. 2010, 59, 967-976.
133. Khamaisi, M.; Potashnik, R.; Tirosh, A.; Demshchak, E.; Rudich, A.; Tritschler, H.; Wessel, K.; Bashan, N. Lipoic acid reduces glycemia and increases muscle glut4 content in streptozotocin-diabetic rats. Metabol. Clin. Exp. 1997, 46, 763-768.
134. Rudich, A.; Tirosh, A.; Potashnik, R.; Khamaisi, M.; Bashan, N. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase b and glucose transport in 3t3-l1 adipocytes. Diabetologia 1999, 42, 949-957.
135. Valdecantos, M.P.; Perez-Matute, P.; Quintero, P.; Martinez, J.A. Vitamin c, resveratrol and lipoic acid actions on isolated rat liver mitochondria: All antioxidants but different. Redox Rep. 2010, 15, 207-216.
136. Tonin, A.M.; Amaral, A.U.; Busanello, E.N.; Grings, M.; Castilho, R.F.; Wajner, M. Long-chain 3-hydroxy fatty acids accumulating in long-chain 3-hydroxyacyl-coa dehydrogenase and mitochondrial trifunctional protein deficiencies uncouple oxidative phosphorylation in heart mitochondria. J. Bioenerg. Biomembr. 2013, 45, 47-57.
137. Sarkar, P.; Zaja, I.; Bienengraeber, M.; Rarick, K.R.; Terashvili, M.; Canfield, S.; Falck, J.R.; Harder, D.R. Epoxyeicosatrienoic acids pre-treatment improves amyloid beta-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes. Am. J. Physiol. Heart Circ. Physiol. 2013.
138. Echtay, K.S.; Esteves, T.C.; Pakay, J.L.; Jekabsons, M.B.; Lambert, A.J.; Portero-Otin, M.; Pamplona, R.; Vidal-Puig, A.J.; Wang, S.; Roebuck, S.J.; et al. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 2003, 22, 4103-4110.
139. Malingriaux, E.A.; Rupprecht, A.; Gille, L.; Jovanovic, O.; Jezek, P.; Jaburek, M.; Pohl, E.E. Fatty acids are key in 4-hydroxy-2-nonenal-mediated activation of uncoupling proteins 1 and 2. PloS One 2013, doi:10.1371/journal.pone.0077786.
140. Nadtochiy, S.M.; Zhu, Q.; Urciuoli, W.; Rafikov, R.; Black, S.M.; Brookes, P.S. Nitroalkenes confer acute cardioprotection via adenine nucleotide translocase 1. J. Biol. Chem. 2012, 287, 3573-3580.
141. Senese, R.; Valli, V.; Moreno, M.; Lombardi, A.; Busiello, R.A.; Cioffi, F.; Silvestri, E.; Goglia, F.; Lanni, A.; de Lange, P. Uncoupling protein 3 expression levels influence insulin sensitivity, fatty acid oxidation, and related signaling pathways. Pflug. Arch. 2011, 461, 153-164.
142. Srivastava, S.; Kashiwaya, Y.; King, M.T.; Baxa, U.; Tam, J.; Niu, G.; Chen, X.; Clarke, K.; Veech, R.L. Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet. FASEB J. 2012, 26, 2351-2362.
143. Kashiwaya, Y.; Pawlosky, R.; Markis, W.; King, M.T.; Bergman, C.; Srivastava, S.; Murray, A.; Clarke, K.; Veech, R.L. A ketone ester diet increases brain malonyl-coa and uncoupling proteins 4 and 5 while decreasing food intake in the normal wistar rat. J. Biol. Chem. 2010, 285, 25950-25956.
144. Sullivan, P.G.; Rippy, N.A.; Dorenbos, K.; Concepcion, R.C.; Agarwal, A.K.; Rho, J.M. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 2004, 55, 576-580.
145. Jikumaru, M.; Hiramoto, K.; Honma, T.; Sato, E.F.; Sekiyama, A.; Inoue, M. Effect of starvation on the survival of male and female mice. Physiol. Chem. Phys. Med. NMR 2007, 39, 247-257.
146. Sanchez-Alvarez, R.; Martinez-Outschoorn, U.E.; Lamb, R.; Hulit, J.; Howell, A.; Gandara, R.; Sartini, M.; Rubin, E.; Lisanti, M.P.; Sotgia, F. Mitochondrial dysfunction in breast cancer cells prevents tumor growth: Understanding chemoprevention with metformin. Cell Cycle 2013, 12, 172-182.
147. Mercader, J.; Ribot, J.; Murano, I.; Felipe, F.; Cinti, S.; Bonet, M.L.; Palou, A. Remodeling of white adipose tissue after retinoic acid administration in mice. Endocrinology 2006, 147, 5325-5332.
148. Amengual, J.; Ribot, J.; Bonet, M.L.; Palou, A. Retinoic acid treatment enhances lipid oxidation and inhibits lipid biosynthesis capacities in the liver of mice. Cell. Physiol. Biochem. 2010, 25, 657-666.
149. Camara, Y.; Mampel, T.; Armengol, J.; Villarroya, F.; Dejean, L. Ucp3 expression in liver modulates gene expression and oxidative metabolism in response to fatty acids, and sensitizes mitochondria to permeability transition. Cell. Phys. Biochem. 2009, 24, 243-252.
150. Pietta, P.G. Flavonoids as antioxidants. J. Nat. Prod. 2000, 63, 1035-1042.
151. Dorta, D.J.; Pigoso, A.A.; Mingatto, F.E.; Rodrigues, T.; Pestana, C.R.; Uyemura, S.A.; Santos, A.C.; Curti, C. Antioxidant activity of flavonoids in isolated mitochondria. Phytother. Res. 2008, 22, 1213-1218.
152. Miyashita, K.; Nishikawa, S.; Beppu, F.; Tsukui, T.; Abe, M.; Hosokawa, M. The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds. J. Sci. Food Agr. 2011, 91, 1166-1174.
153. Schuster, S.; Fell, D.A.; Dandekar, T. A general definition of metabolic pathways useful for systematic organization and analysis of complex metabolic networks. Nat. Biotechnol. 2000, 18, 326-332.
154. Edwards, J.S.; Ibarra, R.U.; Palsson, B.O. In silico predictions of escherichia coli metabolic capabilities are consistent with experimental data. Nat. Biotechnol. 2001, 19, 125-130.
155. Gowda, G.A.; Zhang, S.; Gu, H.; Asiago, V.; Shanaiah, N.; Raftery, D. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn. 2008, 8, 617-633.
156. Shulaev, V. Metabolomics technology and bioinformatics. Brief. Bioinform. 2006, 7, 128-139.
157. Beecher, C.W.W. The human metabolome. In Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis, Harrigan, G.G.; Goodacre, R, Eds.; Springer: Berlin, Germany, 2003.
158. Wishart, D.S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A.C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; et al. Hmdb: The human metabolome database. Nucleic Acids Res. 2007, 35, D521-D526.
159. Weckwerth, W.; Wenzel, K.; Fiehn, O. Process for the integrated extraction, identification and quantification of metabolites, proteins and rna to reveal their co-regulation in biochemical networks. Proteomics 2004, 4, 78-83.
160. Fan, T.W.; Lorkiewicz, P.K.; Sellers, K.; Moseley, H.N.; Higashi, R.M.; Lane, A.N. Stable isotope-resolved metabolomics and applications for drug development. Pharmacol. Therapeut. 2012, 133, 366-391.
161. Smolinska, A.; Blanchet, L.; Buydens, L.M.; Wijmenga, S.S. Nmr and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review. Anal. Chim. Acta 2012, 750, 82-97.
162. Zhou, B.; Xiao, J.F.; Tuli, L.; Ressom, H.W. Lc-ms-based metabolomics. Mol. Biosyst. 2012, 8, 470-481.
163. Koek, M.M.; Jellema, R.H.; van der Greef, J.; Tas, A.C.; Hankemeier, T. Quantitative metabolomics based on gas chromatography mass spectrometry: Status and perspectives. Metabolomics 2011, 7, 307-328.
164. Werner, E.; Heilier, J.F.; Ducruix, C.; Ezan, E.; Junot, C.; Tabet, J.C. Mass spectrometry for the identification of the discriminating signals from metabolomics: Current status and future trends. J. Chromatogr. B 2008, 871, 143-163.
165. Bakken, I.J.; Sonnewald, U.; Clark, J.B.; Bates, T.E. [U-13C]glutamate metabolism in rat brain mitochondria reveals malic enzyme activity. Neuroreport 1997, 8, 1567-1570.
166. Teng, Q.; Ekman, D.R.; Huang, W.; Collette, T.W. Push-through direct injection nmr: An optimized automation method applied to metabolomics. Analyst 2012, 137, 2226-2232.
167. Matuszewski, B.K.; Constanzer, M.L.; Chavez-Eng, C.M. Matrix effect in quantitative lc/ms/ms analyses of biological fluids: A method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 1998, 70, 882-889.
168. Larger, P.J.; Breda, M.; Fraier, D.; Hughes, H.; James, C.A. Ion-suppression effects in liquid chromatography-tandem mass spectrometry due to a formulation agent, a case study in drug discovery bioanalysis. J. Pharmaceut. Biomed. Anal. 2005, 39, 206-216.
169. Lin, Z.; Vicente Goncalves, C.M.; Dai, L.; Lu, H.M.; Huang, J.H.; Ji, H.; Wang, D.S.; Yi, L.Z.; Liang, Y.Z. Exploring metabolic syndrome serum profiling based on gas chromatography mass spectrometry and random forest models. Anal. Chim. Acta 2014, 827, 22-27.
170. Chang, K.L.; New, L.S.; Mal, M.; Goh, C.W.; Aw, C.C.; Browne, E.R.; Chan, E.C. Metabolic profiling of 3-nitropropionic acid early-stage huntington's disease rat model using gas chromatography time-of-flight mass spectrometry. J. Proteome Res. 2011, 10, 2079-2087.
171. Halket, J.M.; Waterman, D.; Przyborowska, A.M.; Patel, R.K.; Fraser, P.D.; Bramley, P.M. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J. Exp.Bot. 2005, 56, 219-243.
172. Oberacher, H.; Whitley, G.; Berger, B. Evaluation of the sensitivity of the "wiley registry of tandem mass spectral data, MSforID" with MS/MS data of the "NIST/NIH/EPA mass spectral library". J. Mass Spectrom. 2013, 48, 487-496.
173. Horai, H.; Arita, M.; Kanaya, S.; Nihei, Y.; Ikeda, T.; Suwa, K.; Ojima, Y.; Tanaka, K.; Tanaka, S.; Aoshima, K.; et al. Massbank: A public repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 2010, 45, 703-714.
174. Heinonen, M.; Shen, H.; Zamboni, N.; Rousu, J. Metabolite identification and molecular fingerprint prediction through machine learning. Bioinformatics 2012, 28, 2333-2341.
175. Gravel, S.P.; Andrzejewski, S.; Avizonis, D.; St-Pierre, J. Stable isotope tracer analysis in isolated mitochondria from mammalian systems. Metabolites 2014, 4, 166-183.
176. Soga, T. Capillary electrophoresis-mass spectrometry for metabolomics. Meth. Mol. Biol. 2007, 358, 129-137.
177. World Health Organization (WHO). Obesity. Available online: http://www.who.int/topics/ obesity/en/ (accessed on 2 September 2014).
178. Wronska, A.; Kmiec, Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol. 2012, 205, 194-208.
179. Duncan, R.E.; Ahmadian, M.; Jaworski, K.; Sarkadi-Nagy, E.; Sul, H.S. Regulation of lipolysis in adipocytes. Ann. Rev. Nutr. 2007, 27, 79-101.
180. Lehr, S.; Hartwig, S.; Lamers, D.; Famulla, S.; Muller, S.; Hanisch, F.G.; Cuvelier, C.; Ruige, J.; Eckardt, K.; Ouwens, D.M.; et al. Identification and validation of novel adipokines released from primary human adipocytes. Mol. Cell. Proteom. 2012, doi:10.1074/mcp.M111.010504.
181. Trayhurn, P.; Wood, I.S. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004, 92, 347-355.
182. Molina, H.; Yang, Y.; Ruch, T.; Kim, J.W.; Mortensen, P.; Otto, T.; Nalli, A.; Tang, Q.Q.; Lane, M.D.; Chaerkady, R.; et al. Temporal profiling of the adipocyte proteome during differentiation using a five-plex silac based strategy. J. Proteome Res. 2009, 8, 48-58.
183. Zhong, J.; Krawczyk, S.A.; Chaerkady, R.; Huang, H.; Goel, R.; Bader, J.S.; Wong, G.W.; Corkey, B.E.; Pandey, A. Temporal profiling of the secretome during adipogenesis in humans. J. Proteome Res. 2010, 9, 5228-5238.
184. Alvarez-Llamas, G.; Szalowska, E.; de Vries, M.P.; Weening, D.; Landman, K.; Hoek, A.; Wolffenbuttel, B.H.; Roelofsen, H.; Vonk, R.J. Characterization of the human visceral adipose tissue secretome. Mol. Cell. Proteom. 2007, 6, 589-600.
185. Ouchi, N.; Parker, J.L.; Lugus, J.J.; Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85-97.
186. Bluher, M. Adipokines-Removing road blocks to obesity and diabetes therapy. Mol. Metabol. 2014, 3, 230-240.
187. Seale, P.; Bjork, B.; Yang, W.; Kajimura, S.; Chin, S.; Kuang, S.; Scime, A.; Devarakonda, S.; Conroe, H.M.; Erdjument-Bromage, H.; et al. Prdm16 controls a brown fat/skeletal muscle switch. Nature 2008, 454, 961-967.
188. Tang, Q.Q.; Lane, M.D. Adipogenesis: From stem cell to adipocyte. Ann. Rev. Biochem. 2012, 81, 715-736.
189. Carobbio, S.; Rosen, B.; Vidal-Puig, A. Adipogenesis: New insights into brown adipose tissue differentiation. J. Mol. Endocrinol. 2013, 51, T75-T85.
190. Heaton, J.M. The distribution of brown adipose tissue in the human. J. Anat. 1972, 112, 35-39.
191. Saito, M.; Okamatsu-Ogura, Y.; Matsushita, M.; Watanabe, K.; Yoneshiro, T.; Nio-Kobayashi, J.; Iwanaga, T.; Miyagawa, M.; Kameya, T.; Nakada, K.; et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: Effects of cold exposure and adiposity. Diabetes 2009, 58, 1526-1531.
192. Van der Lans, A.A.; Hoeks, J.; Brans, B.; Vijgen, G.H.; Visser, M.G.; Vosselman, M.J.; Hansen, J.; Jorgensen, J.A.; Wu, J.; Mottaghy, F.M.; et al. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J. Clin. Investig. 2013, 123, 3395-3403.
193. Rosenwald, M.; Wolfrum, C. The origin and definition of brite versus white and classical brown adipocytes. Adipocyte 2014, 3, 4-9.
194. Virtue, S.; Vidal-Puig, A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 2013, 60, 39-43.
195. Huang, P.L. A comprehensive definition for metabolic syndrome. Dis. Models Mech. 2009, 2, 231-237.
196. Marchesini, G.; Moscatiello, S.; Di Domizio, S.; Forlani, G. Obesity-associated liver disease. J. Clin. Endocrinol. Metabol. 2008, 93, S74-S80.
197. Lavie, C.J.; Milani, R.V.; Ventura, H.O. Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 2009, 53, 1925-1932.
198. Ligibel, J. Obesity and breast cancer. Oncology 2011, 25, 994-1000.
199. James, A.M.; Collins, Y.; Logan, A.; Murphy, M.P. Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol. Metabol. 2012, 23, 429-434.
200. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2004, 114, 1752-1761.
201. Pereira, S.; Park, E.; Mori, Y.; Haber, C.A.; Han, P.; Uchida, T.; Stavar, L.; Oprescu, A.I.; Koulajian, K.; Ivovic, A.; et al. Ffa-induced hepatic insulin resistance in vivo is mediated by pkc-delta, nadph oxidase, and oxidative stress. Am. J. Physiol. Endocrinol. Metabol. 2014, 307, E34-E46.
202. Hirao, K.; Maruyama, T.; Ohno, Y.; Hirose, H.; Shimada, A.; Takei, I.; Murata, M.; Morii, T.; Eguchi, T.; Hayashi, M.; et al. Association of increased reactive oxygen species production with abdominal obesity in type 2 diabetes. Obes. Res. Clin. Pract. 2010, 4, e83-e162.
203. Degasperi, G.R.; Denis, R.G.; Morari, J.; Solon, C.; Geloneze, B.; Stabe, C.; Pareja, J.C.; Vercesi, A.E.; Velloso, L.A. Reactive oxygen species production is increased in the peripheral blood monocytes of obese patients. Metabolism 2009, 58, 1087-1095.
204. Lefort, N.; Glancy, B.; Bowen, B.; Willis, W.T.; Bailowitz, Z.; De Filippis, E.A.; Brophy, C.; Meyer, C.; Hojlund, K.; Yi, Z.; et al. Increased reactive oxygen species production and lower abundance of complex i subunits and carnitine palmitoyltransferase 1b protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 2010, 59, 2444-2452.
205. Dandona, P.; Mohanty, P.; Hamouda, W.; Ghanim, H.; Aljada, A.; Garg, R.; Kumar, V. Inhibitory effect of a two day fast on reactive oxygen species (ros) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations. J. Clin. Endocrinol. Metabol. 2001, 86, 2899-2902.
206. Yu, T.; Robotham, J.L.; Yoon, Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. USA 2006, 103, 2653-2658.
207. Ritov, V.B.; Menshikova, E.V.; He, J.; Ferrell, R.E.; Goodpaster, B.H.; Kelley, D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005, 54, 8-14.
208. Rong, J.X.; Qiu, Y.; Hansen, M.K.; Zhu, L.; Zhang, V.; Xie, M.; Okamoto, Y.; Mattie, M.D.; Higashiyama, H.; Asano, S.; et al. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 2007, 56, 1751-1760.
209. Wilson-Fritch, L.; Nicoloro, S.; Chouinard, M.; Lazar, M.A.; Chui, P.C.; Leszyk, J.; Straubhaar, J.; Czech, M.P.; Corvera, S. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Investig. 2004, 114, 1281-1289.
210. Lee, J.Y.; Lee, D.C.; Im, J.A.; Lee, J.W. Mitochondrial DNA copy number in peripheral blood is independently associated with visceral fat accumulation in healthy young adults. Int. J. Endocrinol. 2014, doi:10.1155/2014/586017.
211. Niemann, B.; Chen, Y.; Teschner, M.; Li, L.; Silber, R.E.; Rohrbach, S. Obesity induces signs of premature cardiac aging in younger patients: The role of mitochondria. J. Am. Coll. Cardiol. 2011, 57, 577-585.
212. Valerio, A.; Cardile, A.; Cozzi, V.; Bracale, R.; Tedesco, L.; Pisconti, A.; Palomba, L.; Cantoni, O.; Clementi, E.; Moncada, S.; et al. Tnf-alpha downregulates enos expression and mitochondrial biogenesis in fat and muscle of obese rodents. J. Clin. Investig. 2006, 116, 2791-2798.
213. Zorzano, A.; Hernandez-Alvarez, M.I.; Palacin, M.; Mingrone, G. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors pgc-1alpha or pgc-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochim. Biophys. Acta 2010, 1797, 1028-1033.
214. Hakansson, J.; Eliasson, B.; Smith, U.; Enerback, S. Adipocyte mitochondrial genes and the forkhead factor foxc2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone. Diabetol. Metab. Syndr. 2011, 3, doi:10.1186/1758-5996-3-32.
215. Austin, S.; St-Pierre, J. Pgc1alpha and mitochondrial metabolism-Emerging concepts and relevance in ageing and neurodegenerative disorders. J. Cell Sci. 2012, 125, 4963-4971.
216. Sharma, K.; Karl, B.; Mathew, A.V.; Gangoiti, J.A.; Wassel, C.L.; Saito, R.; Pu, M.; Sharma, S.; You, Y.H.; Wang, L.; et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J. Am. Soc. Nephrol. 2013, 24, 1901-1912.
217. Fonseca, V.; Rosenstock, J.; Patwardhan, R.; Salzman, A. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: A randomized controlled trial. J. Am. Med. Assoc. 2000, 283, 1695-1702.
218. Chanseaume, E.; Barquissau, V.; Salles, J.; Aucouturier, J.; Patrac, V.; Giraudet, C.; Gryson, C.; Duche, P.; Boirie, Y.; Chardigny, J.M.; et al. Muscle mitochondrial oxidative phosphorylation activity, but not content, is altered with abdominal obesity in sedentary men: Synergism with changes in insulin sensitivity. J. Clin. Endocrinol. Metabol. 2010, 95, 2948-2956.
219. Shen, X.; Zheng, S.; Thongboonkerd, V.; Xu, M.; Pierce, W.M., Jr.; Klein, J.B.; Epstein, P.N. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E896-E905.
220. Kim, J.A.; Wei, Y.; Sowers, J.R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 2008, 102, 401-414.
221. Petersen, P. Abnormal mitochondria in hepatocytes in human fatty liver. Acta Pathol. Microbiol. Scand. 1977, 85, 413-420.
222. Eura, Y.; Ishihara, N.; Yokota, S.; Mihara, K. Two mitofusin proteins, mammalian homologues of fzo, with distinct functions are both required for mitochondrial fusion. J. Biochem. 2003, 134, 333-344.
223. Bach, D.; Pich, S.; Soriano, F.X.; Vega, N.; Baumgartner, B.; Oriola, J.; Daugaard, J.R.; Lloberas, J.; Camps, M.; Zierath, J.R.; et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 2003, 278, 17190-17197.
224. Liu, R.; Jin, P.; LiqunYu; Wang, Y.; Han, L.; Shi, T.; Li, X. Impaired mitochondrial dynamics and bioenergetics in diabetic skeletal muscle. PloS One 2014, 9, e92810.
225. Hackenbrock, C.R. Chemical and physical fixation of isolated mitochondria in low-energy and high-energy states. Proc. Natl. Acad. Sci. USA 1968, 61, 598-605.
226. Mogensen, M.; Sahlin, K.; Fernstrom, M.; Glintborg, D.; Vind, B.F.; Beck-Nielsen, H.; Hojlund, K. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007, 56, 1592-1599.
227. Martin, S.D.; Morrison, S.; Konstantopoulos, N.; McGee, S.L. Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action. Mol. Metab. 2014, 3, 408-418.
228. Sanz, M.N.; Sanchez-Martin, C.; Detaille, D.; Vial, G.; Rigoulet, M.; El-Mir, M.Y.; Rodriguez-Villanueva, G. Acute mitochondrial actions of glitazones on the liver: A crucial parameter for their antidiabetic properties. Cell. Physiol. Biochem. 2011, 28, 899-910.
229. Brunmair, B.; Staniek, K.; Gras, F.; Scharf, N.; Althaym, A.; Clara, R.; Roden, M.; Gnaiger, E.; Nohl, H.; Waldhausl, W.; et al. Thiazolidinediones, like metformin, inhibit respiratory complex i: A common mechanism contributing to their antidiabetic actions? Diabetes 2004, 53, 1052-1059.
230. Pagel-Langenickel, I.; Schwartz, D.R.; Arena, R.A.; Minerbi, D.C.; Johnson, D.T.; Waclawiw, M.A.; Cannon, R.O., 3rd.; Balaban, R.S.; Tripodi, D.J.; Sack, M.N. A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in type 2 diabetes mellitus. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2659-H2666.
231. Newgard, C.B.; An, J.; Bain, J.R.; Muehlbauer, M.J.; Stevens, R.D.; Lien, L.F.; Haqq, A.M.; Shah, S.H.; Arlotto, M.; Slentz, C.A.; et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabol. 2009, 9, 311-326.
232. Prentice, K.J.; Luu, L.; Allister, E.M.; Liu, Y.; Jun, L.S.; Sloop, K.W.; Hardy, A.B.; Wei, L.; Jia, W.; Fantus, I.G.; et al. The furan fatty acid metabolite cmpf is elevated in diabetes and induces beta cell dysfunction. Cell Metabol. 2014, 19, 653-666.
233. Sampey, B.P.; Freemerman, A.J.; Zhang, J.; Kuan, P.F.; Galanko, J.A.; O'Connell, T.M.; Ilkayeva, O.R.; Muehlbauer, M.J.; Stevens, R.D.; Newgard, C.B.; et al. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PloS One 2012, doi:10.1371/journal.pone.0038812.
234. Cummins, T.D.; Holden, C.R.; Sansbury, B.E.; Gibb, A.A.; Shah, J.; Zafar, N.; Tang, Y.; Hellmann, J.; Rai, S.N.; Spite, M.; et al. Metabolic remodeling of white adipose tissue in obesity. Am. J. Physiol. Endocrinol. Metabol. 2014, 307, E262-E277.
235. Won, E.Y.; Yoon, M.K.; Kim, S.W.; Jung, Y.; Bae, H.W.; Lee, D.; Park, S.G.; Lee, C.H.; Hwang, G.S.; Chi, S.W. Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1h nmr spectroscopy. PloS One 2013, doi:10.1371/journal.pone.0075998.
236. Dudzik, D.; Zorawski, M.; Skotnicki, M.; Zarzycki, W.; Kozlowska, G.; Bibik-Malinowska, K.; Vallejo, M.; Garcia, A.; Barbas, C.; Ramos, M.P. Metabolic fingerprint of gestational diabetes mellitus. J. Proteomics 2014, 103, 57-71.
237. Eisinger, K.; Krautbauer, S.; Hebel, T.; Schmitz, G.; Aslanidis, C.; Liebisch, G.; Buechler, C. Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes. Exp. Mol. Pathol. 2014, 97, 37-43.
238. Reinehr, T.; Wolters, B.; Knop, C.; Lass, N.; Hellmuth, C.; Harder, U.; Peissner, W.; Wahl, S.; Grallert, H.; Adamski, J.; et al. Changes in the serum metabolite profile in obese children with weight loss. Eur. J. Nutr. Available online: http://www.ncbi.nlm.nih.gov/pubmed/24740590 (accessed on 17 April 2014).
239. Schafer, N.; Yu, Z.; Wagener, A.; Millrose, M.K.; Reissmann, M.; Bortfeldt, R.; Dieterich, C.; Adamski, J.; Wang-Sattler, R.; Illig, T.; et al. Changes in metabolite profiles caused by genetically determined obesity in mice. Metabolomics 2014, 10, 461-472.
240. Li, F.; Jiang, C.; Larsen, M.C.; Bushkofsky, J.; Krausz, K.W.; Wang, T.; Jefcoate, C.R.; Gonzalez, F.J. Lipidomics reveals a link between cyp1b1 and scd1 in promoting obesity. J. Proteome Res. 2014, 13, 2679-2687.
241. Suganami, T.; Tanaka, M.; Ogawa, Y. Adipose tissue inflammation and ectopic lipid accumulation. Endocr. J. 2012, 59, 849-857.
242. Nobuhara, M.; Saotome, M.; Watanabe, T.; Urushida, T.; Katoh, H.; Satoh, H.; Funaki, M.; Hayashi, H. Mitochondrial dysfunction caused by saturated fatty acid loading induces myocardial insulin-resistance in differentiated h9c2 myocytes: A novel ex vivo myocardial insulin-resistance model. Exp. Cell Res. 2013, 319, 955-966.
243. Yang, C.; Aye, C.C.; Li, X.; Diaz Ramos, A.; Zorzano, A.; Mora, S. Mitochondrial dysfunction in insulin resistance: Differential contributions of chronic insulin and saturated fatty acid exposure in muscle cells. Biosci. Rep. 2012, 32, 465-478.
244. Koves, T.R.; Ussher, J.R.; Noland, R.C.; Slentz, D.; Mosedale, M.; Ilkayeva, O.; Bain, J.; Stevens, R.; Dyck, J.R.; Newgard, C.B.; et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metabol. 2008, 7, 45-56.
245. Sevastou, I.; Kaffe, E.; Mouratis, M.A.; Aidinis, V. Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes. Biochim. Biophys. Acta 2013, 1831, 42-60.
246. Moolenaar, W.H.; Hla, T. Snapshot: Bioactive lysophospholipids. Cell 2012, 148, 378.
247. Basanez, G.; Sharpe, J.C.; Galanis, J.; Brandt, T.B.; Hardwick, J.M.; Zimmerberg, J. Bax-type apoptotic proteins porate pure lipid bilayers through a mechanism sensitive to intrinsic monolayer curvature. J. Biol. Chem. 2002, 277, 49360-49365.
248. Kalous, M.; Rauchova, H.; Drahota, Z. The effect of lysophosphatidylcholine on the activity of various mitochondrial enzymes. Biochim. Biophys. Acta 1992, 1098, 167-171.
249. Kakisaka, K.; Cazanave, S.C.; Fingas, C.D.; Guicciardi, M.E.; Bronk, S.F.; Werneburg, N.W.; Mott, J.L.; Gores, G.J. Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis. Am. J. Physiol. 2012, 302, G77-G84.
250. Eisinger, K.; Liebisch, G.; Schmitz, G.; Aslanidis, C.; Krautbauer, S.; Buechler, C. Lipidomic analysis of serum from high fat diet induced obese mice. Int. J. Mol. Sci. 2014, 15, 2991-3002.
251. Nestel, P.J.; Straznicky, N.; Mellett, N.A.; Wong, G.; de Souza, D.P.; Tull, D.L.; Barlow, C.K.; Grima, M.T.; Meikle, P.J. Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. Am. J. Clin. Nutr. 2014, 99, 46-53.
252. Watkins, S.M.; Reifsnyder, P.R.; Pan, H.J.; German, J.B.; Leiter, E.H. Lipid metabolome-wide effects of the ppargamma agonist rosiglitazone. J. Lipid Res. 2002, 43, 1809-1817.
253. Bao, Y.; Zhao, T.; Wang, X.; Qiu, Y.; Su, M.; Jia, W. Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. J. Proteome Res. 2009, 8, 1623-1630.
254. Zhu, Y.; Feng, Y.; Shen, L.; Xu, D.; Wang, B.; Ruan, K.; Cong, W. Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS). J. Chromatogr. B 2013, 925, 110-116.
255. Huo, T.; Cai, S.; Lu, X.; Sha, Y.; Yu, M.; Li, F. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. J. Pharmaceut. Biomed. Anal. 2009, 49, 976-982.
256. Simon-Szabo, L.; Kokas, M.; Mandl, J.; Keri, G.; Csala, M. Metformin attenuates palmitate-induced endoplasmic reticulum stress, serine phosphorylation of irs-1 and apoptosis in rat insulinoma cells. PloS One 2014, doi:10.1371/journal.pone.0097868.
257. Clarke, C.; Xiao, R.; Place, E.; Zhang, Z.; Sondheimer, N.; Bennett, M.; Yudkoff, M.; Falk, M.J. Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. Mol. Genet. Metab. 2013, 110, 145-152.
258. Eaton, S. Control of mitochondrial beta-oxidation flux. Prog. Lipid Res. 2002, 41, 197-239.
259. Shah, S.H.; Crosslin, D.R.; Haynes, C.S.; Nelson, S.; Turer, C.B.; Stevens, R.D.; Muehlbauer, M.J.; Wenner, B.R.; Bain, J.R.; Laferrere, B.; et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 2012, 55, 321-330.
260. She, P.; Reid, T.M.; Bronson, S.K.; Vary, T.C.; Hajnal, A.; Lynch, C.J.; Hutson, S.M. Disruption of bcatm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 2007, 6, 181-194.
261. Walford, G.A.; Davis, J.; Warner, A.S.; Ackerman, R.J.; Billings, L.K.; Chamarthi, B.; Fanelli, R.R.; Hernandez, A.M.; Huang, C.; Khan, S.Q.; et al. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. Metabolism 2013, 62, 1772-1778.
262. Hsiao, G.; Chapman, J.; Ofrecio, J.M.; Wilkes, J.; Resnik, J.L.; Thapar, D.; Subramaniam, S.; Sears, D.D. Multi-tissue, selective ppargamma modulation of insulin sensitivity and metabolic pathways in obese rats. Am. J. Physiol. Endocrinol. Metab. 2011, 300, E164-E174.
263. Yang, R.; Dong, J.; Zhao, H.; Li, H.; Guo, H.; Wang, S.; Zhang, C.; Wang, S.; Wang, M.; Yu, S.; et al. Association of branched-chain amino acids with carotid intima-media thickness and coronary artery disease risk factors. PloS One 2014, doi:10.1371/journal.pone.0099598.
264. Seifert, E.L.; Fiehn, O.; Bezaire, V.; Bickel, D.R.; Wohlgemuth, G.; Adams, S.H.; Harper, M.E. Long-chain fatty acid combustion rate is associated with unique metabolite profiles in skeletal muscle mitochondria. PloS One 2010, doi:10.1371/journal.pone.0009834.
265. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33, S62-S69.
266. Gohring, I.; Sharoyko, V.V.; Malmgren, S.; Andersson, L.E.; Spegel, P.; Nicholls, D.G.; Mulder, H. Chronic high glucose and pyruvate levels differentially affect mitochondrial bioenergetics and fuel-stimulated insulin secretion from clonal ins-1 832/13 cells. J. Biol. Chem. 2014, 289, 3786-3798.
267. Janzer, A.; German, N.J.; Gonzalez-Herrera, K.N.; Asara, J.M.; Haigis, M.C.; Struhl, K. Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and ntps in cancer stem cells. Proc. Natl. Acad. Sci. USA 2014, 111, 10574-10579.
268. Jang, E.H.; Kim, H.K.; Park, C.S.; Kang, J.H. Increased expression of hepatic organic cation transporter 1 and hepatic distribution of metformin in high-fat diet-induced obese mice. Drug Metabol. Pharmacokinet. 2010, 25, 392-397.
269. Chen, L.; Shu, Y.; Liang, X.; Chen, E.C.; Yee, S.W.; Zur, A.A.; Li, S.; Xu, L.; Keshari, K.R.; Lin, M.J.; et al. Oct1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc. Natl. Acad. Sci. USA 2014, 111, 9983-9988.
270. Abdul-Ghani, M.A.; Muller, F.L.; Liu, Y.; Chavez, A.O.; Balas, B.; Zuo, P.; Chang, Z.; Tripathy, D.; Jani, R.; Molina-Carrion, M.; et al. Deleterious action of fa metabolites on atp synthesis: Possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am. J. Physiol. Endocrinol. Metabol. 2008, 295, E678-E685.
271. Zheng, H.; Yde, C.C.; Arnberg, K.; Molgaard, C.; Michaelsen, K.F.; Larnkjaer, A.; Bertram, H.C. Nmr-based metabolomic profiling of overweight adolescents: An elucidation of the effects of inter-/intraindividual differences, gender, and pubertal development. BioMed Research Int. 2014, 2014, Article 537157.
272. Gkourogianni, A.; Kosteria, I.; Telonis, A.G.; Margeli, A.; Mantzou, E.; Konsta, M.; Loutradis, D.; Mastorakos, G.; Papassotiriou, I.; Klapa, M.I.; et al. Plasma metabolomic profiling suggests early indications for predisposition to latent insulin resistance in children conceived by ICSI. PloS One 2014, doi:10.1371/journal.pone.0094001.
273. Ekberg, N.R.; Brismar, K.; Malmstedt, J.; Hedblad, M.A.; Adamson, U.; Ungerstedt, U.; Wisniewski, N. Analyte flux at a biomaterial-tissue interface over time: Implications for sensors for type 1 and 2 diabetes mellitus. J. Diabetes Sci. Technol.2010, 4, 1063-1072.
274. Sorriento, D.; Pascale, A.V.; Finelli, R.; Carillo, A.L.; Annunziata, R.; Trimarco, B.; Iaccarino, G. Targeting mitochondria as therapeutic strategy for metabolic disorders. Sci. World J. 2014, 2014, Article 604685.
275. Jones, L.R.; Wilson, C.I.; Wadden, T.A. Lifestyle modification in the treatment of obesity: An educational challenge and opportunity. Clin. Pharmacol. Therapeut. 2007, 81, 776-779.